Blog Archive

Αλέξανδρος Γ. Σφακιανάκης

Thursday, March 4, 2021

New approval: Atezolizumab and bevacizumab for first line of unresecable hepatocellular carcinoma

xlomafota13 shared this article with you from Inoreader

Bull Cancer. 2021 Feb;108(2):139-140. doi: 10.1016/j.bulcan.2020.11.011. Epub 2021 Feb 2.

NO ABSTRACT

PMID:33546873 | DOI:10.1016/j.bulcan.2020.11.011

View on the web

No comments:

Post a Comment